<mets:mets OBJID="eprint_1067" LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mets:metsHdr CREATEDATE="2026-07-04T13:58:03Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>Repositori BKPK</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_1067_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>Tinjauan Hasil Uji Coba Pengobatan dan Pencegahan Malaria di Beberapa Tempat Indonesia, 1986-1995</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Emilliana</mods:namePart><mods:namePart type="family">Tjitra</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>In Indonesia, only antimalarials chloroquine/sulfadoxine/sulfalene-pyrimethamine, quinine, and primaguine are available. The development of chloroquine and multidrug resistance poses a therapeutic challenge. In order to obtain alternative antimalarial drugs, trials were conducted of malaria treatment and prophylaxis in several chloroqiune or multidrug resistance areas. The objective of these trials was to asses the efficacy and safety of the alternative antimalarial drugs.      All the trials were mostly open studies in the fields and hospitals. These were collaboration studies between Communicable Diseases Research Center, Communicable Diseases  Control and Environmental Health, Faculty of Medicine of the University of Indonesia, NAMRU-2, and local health staff.       The patients were selected according to the WHO criteria for in-vivo antimalarial drug sensitivity testing. The should sign the informed consent form and they were followed up during the study, for 2 weeks-4 months.      In chloroquine and multidrug resistance areas, mefloquine, haloquine, and artemether are effective and safe for treatment of uncomplicated falciparum malaria. While artesunate was noted effective and safe only in the first 14 days. Halofantrine was also documented effective and safe for vivax malaria treatment. Intramuscular artemether was effective and safe for treatment of  severe and complicated falciparum malaria, particulary in remote areas lacking hospitals and the capacity for intravenous infusion. Primaguine, doxycycline and mefloquine are effective are safe for malaria prophylaxis.      Since the new antimalarials are not yet available in Indonesia, the improvement of efficacy of antimalarial drugs currently available shoulds be studied. Prophylactic drugs which are effective and safe for children, pregnant and lactating women should also be studied.</mods:abstract><mods:classification authority="lcc">QV 243-269 Anti-Inflammatory Agents. AntiInfective Agents. Antineoplastic Agents</mods:classification><mods:originInfo><mods:dateIssued encoding="iso8601">1997</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Badan Penelitian dan Pengembangan Kesehatan</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_1067"><mets:rightsMD ID="rights_eprint_1067_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Repositori BKPK the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Repositori BKPK does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Repositori BKPK is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file ID="eprint_1067_3593_1" SIZE="2085876" OWNERID="http://www.badankebijakan.kemkes.go.id/repositori/id/eprint/1067/1/296-454-1-PB.pdf" MIMETYPE="application/pdf"><mets:FLocat LOCTYPE="URL" xlink:type="simple" xlink:href="http://www.badankebijakan.kemkes.go.id/repositori/id/eprint/1067/1/296-454-1-PB.pdf"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_1067_mods" ADMID="TMD_eprint_1067"><mets:fptr FILEID="eprint_1067_document_3593_1"></mets:fptr></mets:div></mets:structMap></mets:mets>